For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241011:nRSK9504Ha&default-theme=true
RNS Number : 9504H Ovoca Bio PLC 11 October 2024
Ovoca Bio plc
("Ovoca" or the "Company")
Holding(s) in Company
Dublin, Ireland, October 11, 2024 - Ovoca Bio, a biopharmaceutical company
with a focus on women's health, has received notification from Mr. Timothy
McCutcheon that, as of 9 October 2014, he holds an interest in 19,506,203
Ordinary Shares of nominal value €0.125 each, which represents approximately
22.05% of the Company's issued share capital. This percentage shareholding is
based on the latest shares in issue figure of 88,458,806 ordinary shares of
nominal value €0.125 each following the Company's recent sale of ordinary
shares from treasury, as announced on 9 October 2024.
End
For further information:
Ovoca Bio plc
Tim McCutcheon (Chief Executive Officer)
Tel +353 1 661 9819
info@ovocabio.com
Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)
Ivan Murphy / Daragh O'Reilly
Tel: +353 1 679 6363
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END HOLFLFLRIELLLIS